project id: TCGA-CESC; case submitter id: TCGA-MU-A5YI; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.54; rna integrity number: 8.4; age at index: 60; days to birth: -21927; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1951; age at diagnosis: 21927; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic t: T1a1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1053.0; figo stage: Stage IA1; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 593; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-MU-A5YI-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;